Anti-Fc-gamma receptor IIB antibodies and uses thereof
US10407499B2 · kind B2 · utility
1Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2014 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | May 21, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an anti-FcyRIIB antibodies which, in comparison to prior art antibodies, markedly increase ITIM phosphorylation of FcyRIIB and can thus be used for the treatment or prophylaxis of autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.